Observational studyActa ophthalmologica2022

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry.

Pierre-Henry Gabrielle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.